[Functional decerebration presenting the picture of an apallic syndrome due to high dosage majeptil therapy. A contribution to the question of the mode of action and site of attack of certain neuroleptics].
D000328:Adult; D001921:Brain / Q000187:drug effects*; D001933:Brain Stem / Q000187:drug effects; D002540:Cerebral Cortex / Q000187:drug effects; D003655:Decerebrate State / Q000139:chemically induced*; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008032:Limbic System / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D010640:Phenothiazines / Q000008:administration & dosage / Q000009:adverse effects*; D012154:Reticular Formation / Q000187:drug effects; D013788:Thalamus / Q000187:drug effects; D014149:Tranquilizing Agents / Q000494:pharmacology
D010640:Phenothiazines; D014149:Tranquilizing Agents
Funktionelle Decerebration unter dem Bild eines apallischen Syndroms bei hochdosierter Majeptil-Behandlung. Ein Beitrag zur Frage von Wirkungsweise und Angriffspunkten bestimmter Neuroleptica.